Discussion reveals differing interpretations of the HEFCE consultations on OA and licensing battle.
While I agree with much of what they say, in a post on the LSE Impact Blog, Meera Sabaratnam and Paul Kirby write, of the latest round of HEFCE consultations on OA for a post-2014 REF: This isn't how I read the proposed document at all.
No takes yet. Share an insight, caveat, or question.
Martin Paul Eve (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: